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WHEN I started my laboratory at Caltech in 1987,I hung on my door a wall chart from Oncogene
Sciences with all the known proto-oncogenes and their
cellular locations and regulatory relationships. One of
these, ras, was identified by viral and cancer genetics
as a dominant oncogene in many tumors and in trans-
forming retroviruses. The RAS protein is a small GTPase,
which undergoes a cycle of guanine nucleotide ex-
change and hydrolysis. RAS was known to be active
when bound to GTP, but its normal role in the cell was
not known, nor was how it became activated and what it
did once it was. RAS and epidermal growth factor re-
ceptor (EGFR) resided on opposite sides of the wall chart.
The molecular genetics of Caenorhabditis elegans vulval
development allowed us to draw a big arrow between
RAS and EGFR in 1990 and other arrows in 1992. The
intellectual pathway to RAS is a genetic story, the high-
light being 15 years ago when we described the initial
genetic pathway from a cell surface receptor to the ras
proto-oncogene let-60 in C. elegans (Han et al. 1990). This
article places this genetic analysis in perspective.
The genetics of this pathway were worked out in
C. elegans in the context of vulval development (see
Perspectives byHorvitz and Sulston 1990). The anchor
cell of the gonad induces three vulval precursor cells to
generate the vulva (Kimble 1981). In the absence of the
anchor cell, hermaphrodites lack a vulva and cannot lay
eggs because the vulval precursor cells generate only
epidermis. Horvitz and Sulston (1980) had found
vulvaless mutants that mimicked the ablation of the
anchor cell, as well as multivulva mutants in which the
precursor cells generate vulval tissue even in the ab-
sence of the anchor cell (Ferguson et al. 1987). These
observations implied that there must be a signaling
pathway from the anchor cell to the precursor cells.
Among the vulvalessmutants would be those that lacked
this signaling pathway; among the multivulva mutants
would be those in which the signaling pathway might be
constitutively activated.
My own scientific interests evolved from trying to
understand the logic of cell lineage to trying to under-
stand the molecular basis for inductive signaling during
development. This goal led directly to the discovery that
RAS has a crucial role in normal development and acts
downstreamof growth factor receptors such as the EGFR.
I started working on C. elegans because in February 1978
Bob Horvitz showed me the just-published cell lineage
diagrams from his article with John Sulston (Sulston
and Horvitz 1977); it looked as if worm development
had some logical structure, and I thought to myself, ‘‘I
can figure that out.’’ I did not get a chance to actually
work on cell lineage until June 1979, when I started
comparing the essentially invariant lineages of another
free-living nematode, Panagrellus redivivus, with those of
C. elegans to infer how the cell lineages might be ge-
netically programmed (Sternberg and Horvitz 1984).
In Horvitz’s lab I learned to watch C. elegans nuclei and
cells divide. I had earlier learned to watch Physarum
polycephalum nuclei divide as a visiting undergraduate in
Stuart Kauffman’s laboratory at the University of Penn-
sylvania. Mainly, it involved lots of attention, quick note
taking, and not much sleep. My undergraduate advisor
at Hampshire College, Lynn Miller, had told me that to
get a position in a genetics laboratory I should stress my
experience working long hours at tedious jobs under
less-than-optimal conditions.
In Horvitz’s lab I collaborated with and learned from
two talented geneticists with drastically different styles.
Iva Greenwald’s style was intensive genetic analysis of
one locus, which she applied to unc-93 (Greenwald
and Horvitz 1980) and later to lin-12 (Greenwald
et al. 1983). Chip Ferguson’s style was to work with tens
of loci at once (Ferguson and Horvitz 1985, 1989). It
would take him 2 weeks to transfer and clean up his
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600 strains, spreading over both our benches. One
year we puzzled over the vulval pathway working two
shifts, talking each night at 11:30 when Ferguson came
in and the next morning at around 8:30 when I came in.
Eventually I broke down and switched to the all-night
schedule; Ferguson and I would go out for breakfast
at 6:00 am and move our cars out of the forbidden
Massachusetts of Technology (MIT) parking lot to prime
on-the-street locations. From this 2-year conversation
we derived a first pathway for vulval development
(Ferguson et al. 1987). The only viable allele of let-23
was n1045, a strange hypomorph that we do not yet fully
understand (see Aroian and Sternberg 1991; Aroian
et al. 1994). Ferguson had found that let-23(n1045) and
lin-15(n309) suppressed each other’s phenotypes. Dur-
ing this time I realized that let-23 and lin-15 had opposite
effects not only on the vulva precursor cells but also on a
two-celled group, P11/P12, and I was convinced that let-
23 was a key to vulval induction and might encode the
receptor for the inductive signal from the anchor cell.
After an enjoyable postdoc in yeast with IraHerskowitz,
I visited Horvitz at MIT in early 1987. I explained what I
wanted to work on in my laboratory. I was excited about
two genes with interpretable pleiotropies, let-23 and lin-
17 (Sternberg and Horvitz 1988). Horvitz said they
were already trying to clone lin-17, but let-23 was about
third on his handwritten list of potential projects for
new students. He quietly crossed let-23 off his list. lin-17
turned out to encode a WNT receptor, a receptor for
a different type of developmental signal (Sawa et al.
1996).
After writing my first National Institutes of Health
grant application in January 1987, I set out to obtain
additional alleles of let-23 and of other loci that worked
with it, using suppression of lin-15 to focus attention
on the desired mutations. This approach worked. We
eventually screened 100,000 gametes and recovered
only 10 alleles: 2 of let-23, 7 of let-60, and 1 of lin-45. I
carried out a pilot genetic screen while still at the
University of California at San Francisco, when Cynthia
Kenyon kindly let me use her new C. elegans lab. I got the
first suppressor, sy1 (inaugurating my C. elegans strain
collection), and set up the complementation test with a
let-23 allele before going to the Sixth International C.
elegansMeeting at the Cold Spring Harbor Laboratory. I
scored the cross at Greenwald’s new lab in Princeton en
route. Raffi Aroian joined the lab in September 1987
and screened for lin-15 suppressors of which he found
two. L28S, isolated on September 28, carried the third
viable let-23 allele, sy97, while L19O (October 19) be-
came sy90 and defined a locus that we temporarily called
dov-1 for ‘‘dominant vulvaless.’’ Ultimately sy90 was
found to be allelic to let-60. The next summer (1988),
Caltech sophomore Ron Rogge obtained seven more
suppressors but had trouble mapping them in the 10
weeks allotted (most were dominant suppressors but re-
cessive lethal). Rogge actually wanted to be a script writer,
so he moved across town to the University of California
at Los Angeles and Utpal Banerjee’s lab where he iso-
lated Drosophila Sos (more about that later) and ap-
peared in themovie ‘‘Jurassic Park,’’ pipetteman in hand.
When Min Han joined my lab in August 1988, Rogge
gave him the strains and showedhimhow to set up worm
crosses. A fewmonths of mapping later, Han and Aroian
realized that they both were working on let-60 (originally
dov-1) and set out on a blackboard a joint series of ex-
periments that needed to be done to solve this inter-
esting locus. During this same time, Scott Clark andGreg
Beitel in Horvitz’s laboratory found a variety of let-60
alleles by screening for suppressors of a temperature-
sensitive allele of lin-15.
During the 1980s developmental geneticists defined
genes as interesting if they appeared to act as if they
were binary switches (Hodgkin 1984). We called them,
tongue-in-cheek, IDCGs for important developmental
control genes or more seriously, ‘‘switch genes.’’ [As
mentioned above, I had worked with Stuart Kauffman
while an undergraduate and was thus on the lookout for
binary switches controlling development (Kauffman
1973; Thomas 1973).] The paradigmatic switch genes in
C. elegans were lin-12 (Greenwald et al. 1983), lin-14
(Ambros andHorvitz 1984), and tra-1 (Hodgkin 1983),
controlling space, time, and sex, respectively. Their char-
acteristic was that loss-of-function (amorphic) alleles had
an effect on a developmental decision opposite to that
of the effect of gain-of-function (hypermorphic or neo-
morphic) alleles. As described below, let-60 has gain-of-
function alleles that cause a multivulva phenotype (pre-
viously known as lin-34; Ferguson and Horvitz 1985)
and loss-of function alleles that cause a vulvaless pheno-
type. Thus, we were primed to realize that let-60 was a new
switchgene (Beitel et al.1990;Han et al.1990).While loss-
of-function alleles are crucial for inferring gene function,
gain-of-function mutations can indicate the sufficiency
of gene action and can be used in reversion screens
to generate null alleles (e.g., Greenwald and Horvitz
1980). As Hodgkin (1984) describes, this concept of
switch genes was based on the work of Ed Lewis (1994)
who had shown that opposite gf and lf alleles of the
Bithorax complex demonstrated its controlling rather
than its permissive role in developmental decisions.
We eventually realized that let-60 was defined by four
classes of alleles. Loss-of-function alleles are recessive
lethal and were isolated by screens for recessive-lethal
mutations near unc-22 (Rogalski et al. 1982; Clark et al.
1988). Gain-of-function mutations were first isolated on
the basis of their semidominant multivulva phenotype.
The dominant, vulvaless alleles are antimorphs and
were isolated as suppressors of the lin-15multivulva phe-
notype. Recessive hypomorphs that are vulvaless and
semiviablewere also isolated as lin-15 suppressors (Beitel
et al. 1990).
To understand the dominant negative (dn) muta-
tions, Han reverted a dn allele as a dominant, going
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from a vulvaless heterozygote (dn/1) to a wild-type
heterozygote (dn lf/1 1), by obtaining a suppressor
mutation linked to the dn allele. A complementation
test with a recessive-lethal let-60 allele (dn 1/1 lf )
suggested that the dn mutations were let-60 alleles,
provided that they were only cis-dominant. The cis–trans
test could then be done: animals carrying the trans
configuration (dn 1/1 lf ) were dead, while those with
the cis configuration were wild type (dn lf/11). The dn
alleles were thus let-60 alleles. A deletion of the region
does not cause a dominant vulvaless phenotype, so the
dn alleles involve some type of gain of function. Beitel
et al. (1990) have a nice series of hypomorphic alleles,
helping to establish the null phenotype of let-60 as
vulvaless (and lethal). Thus, let-60 is necessary for vulval
induction.
The gf alleles of let-60 were isolated in five separate
screens. In addition to the original ‘‘lin-34’’ allele
(Ferguson and Horvitz 1985), four more were found
as suppressors of vulvaless mutants: by Gregg Jongeward
as a dominant suppressor of let-23 in the same screen
that identified sli-1 (Jongeward et al. 1995), by Dianne
Parry and Stuart Kim as a suppressor of lin-10 in the
same screen that identified gap-1 (Hajnal et al. 1997),
by Scott Clark as a suppressor of let-341, and by Min Han
as a trans dominant suppressor of a let-60(dn). Beitel
et al. (1990) screened for suppressors of the multivulva
phenotype of one of the gf alleles and obtained a
recessive, cis-dominant (and thus intragenic) revertant:
gf/1 and gf 1/ 1 lf are multivulva but gf lf/1 1 is wild
type. The intragenic revertants failed to complement a
let-60 recessive-lethal allele, and thus the dominant
multivulva mutations are also let-60 alleles. This and
other gene dosage studies suggested that increased
function of let-60 is sufficient to cause vulval develop-
ment in the absence of the anchor cell. Taken together,
we then knew that let-60 acts as a switch to control
whether or not vulval precursor cells generate epider-
mis or vulval tissue. Indeed, Beitel et al. (1990) later
found that the sequences of all five dominantmultivulva
alleles involved the identical amino acid substitution in
codon 13, causing a weak activation of let-60 by de-
creasing intrinsic GTPase activity, the mechanism by
which RAS proteins become inactive.
Han also screened for mutations that reverted the
ability of a heterozygous dn mutation (dn/1) to sup-
press the multivulva phenotype of lin-15 by going from
dn/1 to dn lf/11. One of these second-site suppressors
was linked to the balancer chromosome (dpy-20); it was a
new gf allele (dn1/1 gf )! Having a gfmutation induced
on a dpy-20 chromosome allowed us to map let-60 to the
left of dpy-20, setting up the positional cloning described
below. The observation that the dominant-negative al-
leles were suppressed by a gain of function indicated
that the dn form of RAS interfered with RAS activation
rather than blocking interaction with an effector (Han
and Sternberg 1991).
The pathway genetics continued to be satisfying. We
showed that let-60(gf) multivulva mutations suppressed
let-23 recessive vulvaless mutations. We inferred that let-
23 is necessary to activate let-60. The anchor cell induces
the vulva via let-23, which acts via let-60 to promote vulval
differentiation. The next step was to find out what these
two genes encoded.
Clark et al. (1995) had just cloned dpy-20, so we were
looking to its left on the physical map. With a rotation
student, Hiroyuki Mori, Han tried to identify by micro-
injection experiments the cosmid in the region that
included let-60 but soon realized that the physical map
was incorrect, owing to the insertion of a piece of
Escherichia coli sequence into one of the cosmids. When
we told Alan Coulson by fax that the cosmid had E. coli
DNA, he removed it, recalculated the physical map, and
faxed back a very small interval a day later. Han then
identified the cosmid by transformation rescue on New
Year’s Eve 1989 around 9 pm. In that pregenomic era,
going from cosmid to the sequence of a gene was an
involved process. Indeed, it took until May to get sub-
clones and good sequence. Han wasted a month or so
manually sequencing to get a long open reading frame.
When he was ready to use BLAST, the server was down
and it took 3 days to get the result. One night, he left
an excited message on my home answering machine
that let-60 was what sounded like ‘‘RAF,’’ which was
clarified as RAS when I called him. We then knew that
RAS in C. elegans plays critical roles in development and
acts in an intercellular signaling pathway (Han and
Sternberg 1990). What controls RAS? And what does it
actually do?
Meanwhile in 1989, Aroian and Jane Mendel were
trying to clone let-23, which lay in an ill-defined mega-
base-sized region of chromosome II. Aroian mapped
let-23 with Tc1 polymorphisms (using the method of
Ruvkun et al. 1989), determining an approximate lo-
cation as well as a left boundary. Mendel identified the
left breakpoint of mnDf67 (left of rol-6) and made a
genomic library from the mnDf67strain to clone the
deletion breakpoint. She found the right breakpoint,
and this gave a right boundary. Smack in the middle of
this region was a clone called kin-7, which was homol-
ogous to the EGFR tyrosine kinase. In 1989 we faxed
Makoto Koga and Yasumi Ohshima about collaborating
to determine if we both had the same gene; most of the
information on the physical map was unpublished.
Aroian used Koga’s genomic clone to rescue let-23. Koga
obtained the genomic and cDNA sequence of let-23. The
whole collaboration was carried on by fax and mail; we
did not meet until the International C. elegans Meeting
at Madison, Wisconsin, in 1991, well after our joint
article was published (Aroian et al. 1990). LET-23 was
the likely receptor for anchor cell signal, and activation
of LET-23 led to RAS activation.
During this same period, Russell Hill was trying to
clone lin-3, which was still a candidate for the inductive
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signal. This region of the genome was not covered by
cosmids, and one night he had a nightmare that the
contig turned into overlapping hotdogs. The next day he
glued plastic hotdogs to the right side of a paper contig
map as surrogate cosmids. Hill screened for lin-3 alleles
that failed to complement existing vulvaless alleles, using
amutator background that had high levels of transposon
Tc1 activity. He eventually obtained a Tc1 allele that
tagged lin-3 (Hill and Sternberg 1992). There were
three especially pleasing aspects to this study: lin-3 en-
codes an EGF family growth factor, overexpression of lin-
3 causes amultivulva phenotype suppressed bymutations
in let-23 or let-60, and lin-3 is expressed in the anchor cell
at the right time to be the inductive signal.
Andy Golden arrived at Caltech in May 1990 and
quickly cloned a C. elegans raf homolog (lin-45) since
(according to that week’s literature) it interacted phys-
ically with EGFR (LET-23). Golden andHan figured out
that lin-45 encoded RAF and acted downstream of RAS;
lin-45 was the 10th of our lin-15 suppressors (Han et al.
1993). By this time, RAF was known to be an upstream
kinase in the MAP kinase cascade (formally MAP kinase
kinase kinase), and a plausible connection from surface
receptor to nucleus was thus established. However, we
still did not know how LET-23 activates LET-60 RAS.
Our lin-15 screen had been amazingly specific, re-
covering alleles of only three genes. By contrast, Clark,
while a student withHorvitz, screened for suppressors of
a temperature-sensitive mutation of lin-15 and found
many more loci (Clark et al. 1992b). He was swamped
with interesting mutations, many of which are still in
the freezer. He did, fortunately, focus on sem-5, which
became one of the two keys to understanding the
receptor-to-RAS pathway (Clark et al. 1992a). The other
key came from studies of R7 photoreceptor specifica-
tion in the Drosophila eye. During the same period,
Mike Simon and Gerry Rubin worked out their sensi-
tized R7 screen (Simon et al. 1991) and found alleles
defective in RAS as well as in SOS. SOS was also found by
Rogge in his Drosophila work with Banerjee. SOS is a
guanine nucleotide exchange factor for RAS, control-
ling RAS activation. The SEM-5-SOS complex couples
receptor activation to RAS activation. Whereas we were
able to obtain viable or semiviable strains, the Drosoph-
ila geneticists could get even recessive lethal alleles by
dominant enhancement. Having SOS allowed biochem-
ists to confirm the regulatory relationships inferred
from the genetic epistasis experiments. We know in
retrospect that Clark had identified the locus let-341,
which encodes C. elegans SOS early on, and showed that
it acted upstream of RAS, but it proved very difficult to
clone. Its sequence was not even in the 1998 C. elegans
genome article. Chieh Chang, after failing to clone a
SOS homolog during a laboratory rotation, eventually
found the sequence in December 1998. Chang figured
out it was let-341 but only in 2000, by which time the
game was over (Chang et al. 2000).
The initial pathway of let-23 controlling let-60 activity
was discovered in 1990. By 1993, we in C. elegans had put
together a linear pathway with lin-3, let-23, sem-5, let-60,
and lin-45 (see Figure 1). Studies in Drosophila and
mammalian cell lines were also hot on the trail of the
RAS pathway, and progress was rapid during these 3
years. In 1993, a physical interaction of RAS andRAFwas
demonstrated, assembling the complete pathway. The
genetic analysis came to fruition at just the right time to
inform the definitive biochemical experiments. There
still is too large a gap between our ability to study,
by molecular genetics, proteins acting in a multicel-
lular organism in vivo and our ability to do single-cell
biochemistry. Fortunately, the conservation of signal-
ing pathways has allowed their elucidatation by the
combination of whole-organism genetics coupled with
biochemistry and cell biology applied in vitro or to
heterologous systems. The gap has been narrowed by
mouse molecular genetics on the mammalian side and
by in vivo imaging techniques on the model organism
side.
The similarities between the RAS signaling pathways
of C. elegans, Drosophila melanogaster, and mammalian
cells served as a key example of conserved core animal
signal transduction. Earlier studies of yeast, for exam-
ple, the complementation of a Schizosaccharomyces pombe
cell-cycle mutant with the human cyclin-dependent
kinase cdc2 (Lee and Nurse 1987), had demonstrated
deep conservation at the level of individual proteins and
of core eukaryotic pathways such as the cell cycle. These
studies andmany others that followed led to our current
expectation that regulatory pathways will be conserved.
This conservation hasmademolecular genetics ofmodel
organisms a standard tool in understanding pathways of
interest to human biology. The pathway to RAS was also a
pathway to the age of model organisms.
I thank Bob Horvitz for showing me my first C. elegans cell division
and for his generosity when I returned as a ‘‘ghost’’ to work on the
vulva. I especially thankmymany colleagues formaking the pathway to
RAS so exhilarating, productive, and fun.
Figure 1.—The genetic pathway to RAS. C. elegans proteins
are indicated in boldface type; the mammalian proteins are in
regular type. Arrows indicate positive regulation. The pathway
was inferred from tests of epistasis between loss-of-function
mutations with a vulvaless phenotype and gain-of-function
mutations or transgenes with a multivulva phenotype.
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